Table 3.

30-Day and 2-year clinical outcomes after TAVR in patients treated vs. not treated with ACEI/ARB

	ACEI/ARB treatment (n = 1736)	No ACEI/ARB treatment (n = 2243)	P-value
30-Day
All-cause death	2.3 (40)	3.2 (71)	0.10
Cardiovascular	1.8 (32)	2.5 (56)	0.16
Non-cardiovascular	0.5 (8)	0.7 (15)	0.38
Disabling stroke	2.0 (34)	2.1 (46)	0.83
Death or disabling stroke	3.9 (67)	4.8 (107)	0.16
Myocardial infarction	1.3 (23)	1.2 (27)	0.74
Periprocedural	0.8 (14)	0.9 (20)	0.77
Major vascular complicationsa	7.1 (123)	7.5 (167)	0.66
Life threatening or disabling bleedinga	5.8 (101)	7.1 (160)	0.09
Acute kidney injurya	18.8 (265)	17.8 (326)	0.36
New permanent pacemaker	10.8 (187)	10.1 (224)	0.45
2-Year
All-cause death	18.6 (316)	27.5 (606)	<0.0001
Cardiovascular	12.3 (203)	17.9 (378)	<0.0001
Non-cardiovascular	7.2 (113)	11.7 (228)	<0.0001

Values are % (n).

^aAccording to VARC 2 definition.